To investigate whether AT9283 may affect MKK3 oncogenic functions abrogating CRC invasiveness, we first assessed the role of MKK3 in modulating the expression of well-known markers of the epithelial-mesenchymal transition (EMT). Here, MAP2K3 is linked to colorectal carcinoma.